Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 15, 2025 $750.78 -0.61% $748.19 V 99.65% 5
Sep 15, 2025 Bullish $748.19 X 0
Sep 10, 2025 Bullish $754.62 V 1
Sep 2, 2025 $723.90 -1.19% $735.19 X 98.46% 0
Sep 2, 2025 $727.15 -0.74% $735.19 X 98.91% 1
Sep 2, 2025 $777.00 +6.06% $735.19 V 94.31% 1
Aug 29, 2025 $722.87 -1.24% $732.58 X 98.67% 1
Aug 29, 2025 $726.28 -0.78% $732.58 X 99.14% 2
Aug 29, 2025 $777.00 +6.15% $732.58 V 93.94% 1
Aug 19, 2025 $687.63 -1.49% $703.21 X 97.78% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE